DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters

Abstract

Embodiments relate generally to lanthanide nanocrystals as ultraviolet downconverters.

Inventors:
;
Issue Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1823867
Patent Number(s):
10982136
Application Number:
15/442,441
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Classifications (CPCs):
C - CHEMISTRY C09 - DYES C09K - MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
H - ELECTRICITY H01 - BASIC ELECTRIC ELEMENTS H01L - SEMICONDUCTOR DEVICES
DOE Contract Number:  
AC02-05CH11231
Resource Type:
Patent
Resource Relation:
Patent File Date: 02/24/2017
Country of Publication:
United States
Language:
English

Citation Formats

Agbo, Peter, and Abergel, Rebecca J. Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters. United States: N. p., 2021. Web.
Agbo, Peter, & Abergel, Rebecca J. Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters. United States.
Agbo, Peter, and Abergel, Rebecca J. Tue . "Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters". United States. https://www.osti.gov/servlets/purl/1823867.
@article{osti_1823867,
title = {Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters},
author = {Agbo, Peter and Abergel, Rebecca J.},
abstractNote = {Embodiments relate generally to lanthanide nanocrystals as ultraviolet downconverters.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2021},
month = {4}
}

Works referenced in this record:

Biosynthetic binding proteins for immunotargeting
patent, May 1998


Nanostructured functional coatings and devices
patent, January 2015


Ligand-Sensitized Lanthanide Nanocrystals as Ultraviolet Downconverters
patent-application, October 2017


Luminescent 1-Hydroxy-2-Pyridinone Chelates of Lanthanides
patent-application, January 2010


Bispecific and oligospecific mono-and oligovalent receptors, the preparation and use thereof
patent, January 1997


Desferrithiocin Analogs and Uses Thereof
patent-application, October 2016


Cells expressing a modified T cell receptor
patent, January 2013


Processing fissile material mixtures containing zirconium and/or carbon
patent, July 2013


Hydroxypyridonate chelating agents
patent, October 1987


Hydroxypyridonate and hydroxypyrimidinone chelating agents
patent-application, January 2005


Bispecific Module Binding TLR9 and CD32 and Comprising a T Cell Epitope for Treatment of Allergies
patent-application, December 2016


Method for processing spent nuclear reactor fuel
patent, July 1981


Process for preparing sertraline intermediates
patent, August 1995


Recombinant antibodies specific for a growth factor receptor
patent, November 1996


Composition and method for upconversion of light and devices incorporating same
patent, October 2016


Grouped Separation of Actinides from a Highly Acidic Aqueous Phase
patent-application, July 2009


Chelating Molecules
patent-application, January 2021


Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
patent, December 1996


Single-Stranded and Double-Stranded Oligonucleotides Comprising a Metal-Chelating Ligand
patent-application, October 2011


Combination Treatment of Hydroxpyridonate Actinide/Lanthanide Decorporation Agents
patent-application, August 2012


Photovoltaic Device and Method for Making
patent-application, May 2012


3-hydroxy-2(1H)-pyridinone chelating agents
patent, April 1999


Separation of Metal Ions By Liquid-Liquid Extraction
patent-application, September 2019


Altered polypeptides with increased half-life
patent, February 1999


Method of using a catheter sleeve
patent, June 1997


Photovoltaic cell
patent, January 1996


Electro-kinetic air transporter-conditioner devices with interstitial electrode
patent-application, September 2002


Hydroxypyridonate and hydroxypyrimidinone chelating agents
patent, January 2005


Desferrithiocin Polyether Analogues
patent-application, August 2014


Formulations and Treatments Employing Hydroxypyridonate Actinide/Lanthanide Decorporation Agents
patent-application, June 2019